Determination of biological activity of alprazolam, triazolam and their metabolites

V. Sethy,D. W. Harris
DOI: https://doi.org/10.1111/J.2042-7158.1982.TB04197.X
1982-02-01
Abstract:The benzodiazepines are psychoactive drugs with wide therapeutic applications as anxiolytics, anticonvulsants, and muscle relaxants (Zbinden 8: Randall 1967). Their site and mechanism of action have recently become the subject of extensive investigations because of the availability of tritium-labelled diazepam and flunitrazepam with high specific activity. Using these ligands. in vitro and in vivo binding studies have indicated that a specific high affinity binding site, the 'benzodiazepine receptor', in the brain may be relevant to the pharmacological action of the drugs (Mohler & Okada 1977; Squires & Braestrup 1977; Tallman et al 1979). Triazolobenzodiazepines. like alprazolam and triazolam, have been found to be both anxiolytic and hypnotic in man (Fabre & McLendon 1979; Chatwin &John 1976) in whom these drugs are metabolized to hydroxylated compounds and benzophenones, which are excreted in urine (Eberts et al 1980, 1981). The activity of alprazolam. triazolam and their metabolites on the benzodiazepine receptor is not known. We have undertaken to determine the activity of these compounds on benzodiazepine receptors by using [3H]flunitrazepam ([?H]FNZ) binding to crude rat brain membrane preparations. The results of in vitro [7H]FNZ binding assays were compared with the in vivo ED5Os of these compounds required to protect the mice against leptazol(pentetrazo1)and nicotine-induced seizures and against hypoxic stress. Benzodiazepine receptor binding assays were carried out according to Speth et al (1979). Male Sprague-Dawley rats (180-200 g) were decapitated. their brains quickly removed and, minus cerebellum, homogenized in 10 volumes of cold (4 "C) distilled water. using a Brinkman Polytron PCU-110 homogenizer for 30 s at setting No 6. and centrifuged at
Medicine,Biology,Chemistry
What problem does this paper attempt to address?